Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 9:13:3611-3616.
doi: 10.2147/DMSO.S275898. eCollection 2020.

Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications

Yohannes Tsegyie Wondmkun  1
Affiliations
Review

Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications

Yohannes Tsegyie Wondmkun. Diabetes Metab Syndr Obes. .

Abstract

Obesity is a triggering factor for diabetes associated with insulin resistance. In individuals who are obese, higher amounts of non-esterified fatty acids, glycerol, hormones, and pro-inflammatory cytokines that could participate in the development of insulin resistance are released by adipose tissue. Besides, endoplasmic reticulum stress, adipose tissue hypoxia, oxidative stress, lipodystrophy, and genetic background have a role in insulin resistance. However, no effective drug therapy was developed for type 2 diabetes mellitus targeting these physiological factors. This is might be due to a lack of agreement on the comprehensive mechanism of insulin resistance. Therefore, this review assesses the cellular components of each physiologic and pathophysiologic factors that are involved in obesity associated insulin resistance, and may encourage further drug development in this field.

Keywords: insulin; insulin resistance; obesity; type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The author declares no competing interests.

References

    1. Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005;26(2):19. - PMC - PubMed
    1. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. 2006;7(2):85–96. doi:10.1038/nrm1837 - DOI - PubMed
    1. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest. 2000;106(4):453. doi:10.1172/JCI10762 - DOI - PMC - PubMed
    1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053. doi:10.2337/diacare.27.5.1047 - DOI - PubMed
    1. Christopher B, Newgard CB. Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9:193–205. doi:10.1038/nrm2327 - DOI - PubMed